Silvia Perez-Vilar

11PUBLICATIONS
49CO-AUTHORS
Implementation science and evaluationToxicology (incl. clinical toxicology)Epidemiological modellingClinical chemistry (incl. diagnostics)Sub-acute care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 14, 2026
Identifying COVID-19 Disease Severity in Real-World Data: Implications for Medical Product Effectiveness Studies.

Mayura U Shinde, Katherine Shapiro, Laura Hou

|Nov 10, 2025
Validation of the US Food and Drug Administration's COVID-19 Disease Severity Categorization for Use in Real-World Data.

Silvia Perez-Vilar, Wei Hua, Andrew Kwist

|Nov 25, 2024
Antipsychotics and Risk of Acute Respiratory Failure in U.S. Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease.

Silvia Perez-Vilar, Andrew D Mosholder, Elizabeth R Smith

|Oct 23, 2024
Trends in Medical Encounters Involving Cannabis-Related Disorders Among US Medicare Beneficiaries, 2017-2022.

Silvia Perez-Vilar, Sara Kazemian, Christina Greene

|Oct 17, 2024
Dexamethasone Dose for COVID-19 in a Large U.S. Hospital Network From April 2020 to May 2023.

Marie C Bradley, Ashish Rai, Austin Cosgrove

Pageof 2